𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Further study needed to define the place of leflunomide in rheumatoid arthritis


Book ID
120865429
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2001
Weight
133 KB
Volume
1310
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The efficacy and safety of leflunomide i
✍ J. R. Kalden; M. Schattenkirchner; H. SΓΆrensen; P. Emery; C. Deighton; B. Rozman πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t